BioStock: PHI aims for US listing

Swedish Medtech Phase Holographic Imaging is making significant strides in the United States, establishing itself at the forefront of the rapidly growing regenerative medicine field. PHI is now taking an important step by applying for listing its shares in the US OTCQB market to enhance its presence and opportunities in the US. BioStock talked to CEO Patrik Eschricht to learn more about what this means for the company.

Read the full article at biostock.se:

https://www.biostock.se/2024/07/phi-aims-for-us-listing/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se